Effect of the oral leukotriene D antagonist LY171883 on inhaled and intradermal challenge with antigen and leukotriene D in atopic subjects

This publication has 9 references indexed in Scilit:

• Dose-related antagonism of leukotriene D4-induced bronchoconstriction by p.o. administration of LY-171883 in nonasthmatic subjects.
  The Journal of Pharmacology and Experimental Therapeutics, 1988
• Effects of a 5-lipoxygenase inhibitior (L-651,392) on primary and late pulmonary responses to ascaris antigen in the squirrel monkey
  Inflammation Research, 1987
• Oral nafazatrom in man: effect on inhaled antigen challenge.
  British Journal of Clinical Pharmacology, 1987
• The effect of an oral leukotriene D4 antagonist L-649,923 on the response to inhaled antigen in asthma*1
  Journal of Allergy and Clinical Immunology, 1987
• Effect of inhaled piriprost (U-60, 257) a novel leukotriene inhibitor, on allergen and exercise induced bronchoconstriction in asthma.
  Thorax, 1986
• The effect of an orally active leukotriene D4/E4 antagonist, LY171883, on antigen-induced airway responses in allergic sheep
  Prostaglandins, 1986
• Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects.
  Thorax, 1984
• Peptide Leukotriene Release after Antigen Challenge in Patients Sensitive to Ragweed
  New England Journal of Medicine, 1984
• Generation of leukotrienes by purified human lung mast cells.
  Journal of Clinical Investigation, 1982